Primary objective: To review the research literature on pharmacological interventions used
in the acute phase of acquired brain injury (ABI) to manage ICP and improve neural …

Objective: To summarize literature describing use of neuromuscular blocking agents
(NMBAs) for common critical care indications and provide a review of NMBA pharmacology …

The decision to treat a patient in the intensive care unit (ICU) with neuromuscular blocking
agents (NMBAs)(for reasons other than the placement of an endotracheal tube) is a difficult …

We have evaluated the effects of a single bolus dose of rocuronium 0.6 mg kg-1 (group 1, n=
10) or vecuronium 0.1 mg kg-1 (group 2, n= 10) on intracranial pressure (ICP), mean arterial …

Drugs for neurosurgical patients should not increase intracranial pressure (ICP) or change
cerebral perfusion pressure (CPP) and cerebral blood flow. This double-blind, cross-over …

Background: For neuroanesthesia and neurocritical care the use of drugs that do not
increase or preferentially decrease intracranial pressure (ICP) or change cerebral perfusion …

Secondary brain injury is associated with a reduction in cerebral blood flow, oxygenation
and perfusion related to hypotension, hypoxemia and raised intracranial pressure. This has …

Skeletal muscle relaxants have their place in everyday use in numerous anesthesiological
procedures, such as preparing a patient for surgery, supporting mechanical ventilation, and …

Obiective: Noi am încercat, în lumina ultimelor date din literatură, să actualizăm ghidurile de
utilizare a miorelaxantelor în terapia intensivă. De asemenea ne propunem trecerea în …